Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) improves the innate immune response and enhances survival in murine polymicrobial sepsis

Critical Care Medicine

Volumn 38, Issue 11, 2010, Pages 2169-2174

  Cziupka, Katharina ^a   Busemann, Alexandra ^a   Partecke, Lars Ivo ^a   Pötschke, Christian ^a   Rath, Matthias ^a   Traeger, Tobias ^a   Koerner, Pia ^a   Von Bernstorff, Wolfram ^a   Kessler, Wolfram ^a   Diedrich, Stephan ^a   Weiss, Frank Ulrich ^a   Maier, Stefan ^a   Bröker, Barbara M ^a   Heidecke, Claus Dieter ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

CASP; sepsis; TRAIL

Indexed keywords

RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; CHEMOKINE; CYTOKINE; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CELL MIGRATION; COLON ASCENDENS STENT PERITONITIS; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; INNATE IMMUNITY; INTESTINE FLORA; MESENTERY LYMPH NODE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PERITONITIS; POLYMICROBIAL SEPSIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SEPSIS; SPLEEN; SURVIVAL; ANIMAL; APOPTOSIS; BIOSYNTHESIS; BLOOD; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MICROBIOLOGY; MORTALITY; NEUTROPHIL CHEMOTAXIS;

ANIMALS; APOPTOSIS; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNITY, INNATE; INJECTIONS, INTRAVENOUS; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; NEUTROPHILS; PERITONEAL CAVITY; PERITONITIS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECOMBINANT PROTEINS; SEPSIS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 78049415108     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181eedaa8     Document Type: Article

References (16)

1. Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, et al: Epidemiology of sepsis in Germany: Results from a national prospective multicenter study. Intensive Care Med 2007;33:606-618
2. Maier S, Traeger T, Entleutner M, Westerholt A, Kleist B, Huser N, Holzmann B, Stier A, Pfeffer K, Heidecke CD: Cecal ligation and puncture versus colon ascendens stent peritonitis: Two distinct animal models for polymicrobial sepsis. Shock 2004;21:505-511
3. Cretney E, Takeda K, Smyth MJ: Cancer: novel therapeutic strategies that exploit the TNF-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway. Int J Biochem Cell Biol 2007;39:280-286
4. Tsokos GC, Tsokos M: The TRAIL to arthritis. J Clin Invest 2003;112:1315-1317
5. Song K, Chen Y, Goke R, Wilmen A, Seidel C, Goke A, Hilliard B: Tumor necrosis factorrelated apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med 2000;191:1095-1104
6. Hilliard B, Wilmen A, Seidel C, Liu TS, Goke R, Chen Y: Roles of TNF-related apoptosisinducing ligand in experimental autoimmune encephalomyelitis. J Immunol 2001;166:1314-1319
7. Wang SH, Chen GH, Fan Y, Van Antwerp M, Baker JR Jr: Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells. Endocrinology 2009;150:2000-2007
8. Finnberg N, Klein-Szanto AJ, El-Deiry WS: TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis. J Clin Invest 2008;118:111-123
9. Hoffmann O, Priller J, Prozorovski T, Schulze-Topphoff U, Baeva N, Lunemann JD, Aktas O, Mahrhofer C, Stricker S, Zipp F, Weber JR: TRAIL limits excessive host immune responses in bacterial meningitis. J Clin Invest 2007;117:2004-2013
10. Lum JJ, Bren G, McClure R, Badley AD: Elimination of senescent neutrophils by TNF-related apoptosis-inducing [corrected] ligand. J Immunol 2005;175:1232-1238
11. Weckmann M, Collison A, Simpson JL, Kopp MV, Wark PA, Smyth MJ, Yagita H, Matthaei KI, Hansbro N, Whitehead B, et al: Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease. Nat Med 2007;13:1308-1315
12. Lamkanfi M, Moreira LO, Makena P, Spierings DC, Boyd K, Murray PJ, Green DR, Kanneganti TD: Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival. Blood 2009;113:2742-2745
13. Qin S, Wang H, Yuan R, Li H, Ochani M, Ochani K, Rosas-Ballina M, Czura CJ, Huston JM, Miller E, et al: Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med 2006;203:1637-1642
14. Hotchkiss RS, Chang KC, Swanson PE, Tinsley KW, Hui JJ, Klender P, Xanthoudakis S, Roy S, Black C, Grimm E, et al: Caspase inhibitors improve survival in sepsis: A critical role of the lymphocyte. Nat Immunol 2000;1:496-501
15. Mahalingam D, Szegezdi E, Keane M, Jong S, Samali A: TRAIL receptor signalling and modulation: Are we on the right TRAIL? Cancer Treat Rev 2009;35:280-288
16. Hasegawa H, Yamada Y, Harasawa H, Tsuji T, Murata K, Sugahara K, Tsuruda K, Masuda M, Takasu N, Kamihira S: Restricted expression of tumor necrosis factor-related apoptosis-inducing ligand receptor 4 in human peripheral blood lymphocytes. Cell Immunol 2004;231:1-7